In Phase 1b Study, Patients Treated in First-Line Demonstrated a Confirmed Objective Response Rate of 65% THOUSAND OAKS, Calif., Sept. 10, 2023 /PRNewswire/ — Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a Phase 1b study evaluating LUMAKRAS® (sotorasib) with carboplatin and pemetrexed in adult patients with … Read more
BEIJING, Sept. 9, 2023 /PRNewswire/ — A report from People’s Daily: A ceremony marking the entry of troops into the Chinese People’s Liberation Army (PLA) support base in Djibouti was held at the base’s barracks on August 1, 2017, marking the completion and official operation of the base. Then Chief of General Staff of Djibouti … Read more
NEW YORK, Sept. 8, 2023 /PRNewswire/ — Quantzig, a leading analytics advisory firm, once again proved its prowess in driving innovation and efficiency across industries. Through a groundbreaking smart automation initiative, we revolutionized the integrated manufacturing processes of a prominent pharmaceutical company, propelling them to new heights of productivity and excellence. In a bid to address … Read more
DUBLIN, Sept. 7, 2023 /PRNewswire/ — The “Global Pathogen Reduction Systems Market Report and Forecast 2023-2031” report has been added to ResearchAndMarkets.com’s offering. The global pathogen reduction systems market is poised for robust growth, with an anticipated compound annual growth rate (CAGR) of 19.80% during the forecast period from 2023 to 2031. This surge is primarily … Read more
Booth C328 ESCRS – Masterclass on contact-free treatments of peripheral tears will showcase easy to control retinal laser care with an image-guided platform beyond slit-lamp lasers TELTOW, Germany, Sept. 7, 2023 /PRNewswire/ — Just in time for the ESCRS conference taking place Sep 8-11, 2023 in Vienna, OD-OS GmbH is announcing that its Quality Management System … Read more
CHALFONT, Pa., Sept. 6, 2023 /PRNewswire/ — Project Transition, serving individuals with serious mental illness and co-occurring substance use disorders along with PCS Mental Health, LLC which serves those with severe mental illness in the forensic arena, has named Dr. Stacey Dixon as the new President effective immediately. Dr. Dixon is a licensed psychologist with … Read more
Distinguished, world renowned experts appointed to strengthen the development of Phanes’ three clinical programs in oncology SAN DIEGO, Sept. 5, 2023 /PRNewswire/ — Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on innovative drug discovery and development in oncology, today announced that it has formed a Clinical Advisory Board (CAB) to enhance the … Read more
NEW YORK, Sept. 4, 2023 /PRNewswire/ — The dental curing lights market size is estimated to increase by USD 107.14 million from 2022 to 2027. The market’s growth momentum will progress at a CAGR of 7.05%. The rising prevalence of dental diseases is expected to drive market growth. The prevalence of tooth decay and other oral health problems is … Read more
Development of Bacteriophages targeting strains causing urinary tract infections Establishment of collaboration with the US Army and investigation of groundwork for entering the US defense market BOSTON and SEOUL, South Korea, Sept. 3, 2023 /PRNewswire/ — iNtRON Biotechnology (“iNtRON”, www.intodeworld.com) has announced today that its New Drug Part has entered into an official contract with the U.S. … Read more
NEW YORK, Sept. 3, 2023 /PRNewswire/ — The healthcare IT market in Saudi Arabia size is estimated to increase by USD 1.6032 billion from 2022 to 2027, with a CAGR of 9.06%, according to a recent market study by Technavio. A remarkable increase in the detection of chronic diseases drives the growth of the healthcare IT market in Saudi Arabia. Diabetes is … Read more